BioCentury
ARTICLE | Company News

Sequus, Tecnofarma S.A.I.C.F. and Laboratorios Raffo S.A. sales and marketing update

June 30, 1997 7:00 AM UTC

Tecnofarma received exclusive rights to market Amphocil in South America for five years. SEQU has an option to co-market the drug in South America after the initial five-year period. ...